Respiratory infections in diabetes: Reviewing the risks and challenges

Journal of Respiratory Diseases

Volumn 29, Issue 7, 2008, Pages 285-293

  Ahmed, Mohammed S ^a,b   Reid, Erin ^a   Khardori, Nancy ^a,c  

^a SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Division of Infectious Diseases

^c Department of Internal Medicine

Author keywords

Diabetes mellitus; Fungal infections; Influenza; MRSA; Pneumonia; Tuberculosis

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AZTREONAM; BETA LACTAM ANTIBIOTIC; CEFEPIME; CEFOTAXIME; CEFPODOXIME; CEFTRIAXONE; CEFUROXIME; CIPROFLOXACIN; DOXYCYCLINE; ERTAPENEM; GLUCOSE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IMIPENEM; INSULIN; ISONIAZID; LEVOFLOXACIN; LINEZOLID; MACROLIDE; MEROPENEM; ORAL ANTIDIABETIC AGENT; PENICILLIN DERIVATIVE; PIPERACILLIN PLUS TAZOBACTAM; PYRAZINAMIDE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; SULTAMICILLIN; UNINDEXED DRUG; VANCOMYCIN;

BACTERIAL PNEUMONIA; COMMUNITY ACQUIRED PNEUMONIA; DIABETES MELLITUS; DIABETIC PATIENT; DISEASE SEVERITY; DRUG HYPERSENSITIVITY; GLUCOSE BLOOD LEVEL; HUMAN; INFLUENZA; LUNG ASPERGILLOSIS; LUNG TUBERCULOSIS; MORBIDITY; MORTALITY; NERVE INJURY; NONHUMAN; OUTCOME ASSESSMENT; PLEURA EFFUSION; PROGNOSIS; RESPIRATORY TRACT INFECTION; REVIEW;

EID: 49049090961     PISSN: 0194259X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (78)

1. Muller LM, Gorter KJ, Hak E, et al. Increased risk of common infections in patients with type 1 and 2 diabetes mellitus. Clin Infect Dis. 2005;41:281-288.
2. Kaslow RA. Infections in diabetes. In: Harris MI, Hammon RF, eds. Diabetes in America. Bethesda, MD: National Institutes of Health; 1985:XIXI-18. NIH publication 85-1468.
3. Infections and diabetes mellitus. West J Med. 1979;130:515-521.
4. Reynolds HY. Integrated host defense against infections. In: Crystal RG, West JB, eds. The Lung: Scientific Foundations. New York: Raven Press Ltd; 1991:1899.
5. Shelhamer JH, Toews GB, Masur H, et al. NIH conference. Respiratory disease in the immunosuppressed patient. Ann Intern Med. 1992;117:415-431.
6. Saiepour D, Sehlin J, Oldenborg PA. Insulin inhibits phagocytosis in normal human neutrophils via PKC alpha/beta-dependent priming of F-actin assembly. Inflamm Res. 2006;55:85-91.
7. Turina M, Fry DE, Polk HC Jr. Acute hyperglycemia and innate immune system: clinical, cellular, and molecular aspects. Crit Care Med. 2005;33:1624-1633.
8. Koziel H, Koziel MJ. Pulmonary complications of diabetes mellitus. Infect Dis Clin North Am. 1995;9:65-96.
9. Bhattacharya SK, Shastri S, Mahajan R et al. Polymorphonuclear leukocyte function in type-2 diabetes mellitus patients and its correlation with glycemic control. Nepal Med Coll J. 2007;9:111-116.
10. Geerlings SE, Hoepelman AI. Immune dysfunction in patients with diabetes mellitus (DM). FEMS Immunol Med Microbiol. 1999;26:259-265.
11. Delamaire M, Maugendre D, Moreno M, et al. Impaired leukocyte function in diabetic patients. Diabet Med. 1977;14:29-34.
12. Valerius NH, Eff C, Hansen NE, et al. Neutrophil and lymphocyte function in patients with diabetes mellitus. Acta Med Scand. 1982;211:463-472.
13. Ljubic S, Metelko Z, Car N, et al. Reduction of diffusion capacity for carbon monoxide in diabetic patients. Chest. 1998;114:1033-1035.
14. Peleg AY, Weerarathna T, McCarthy JS, Davis TM. Common infections in diabetes: pathogenesis, management and relationship to glycaemic control. Diabetes Metab Res Rev. 2007;23:3-13.
15. Lange P, Parner J, Schnohr P, Jensen G. Copenhagen City Heart Study: longitudinal analysis of ventilatory capacity in diabetic and nondiabetic adults. Eur Respir J. 2002;20:1406-1412.
16. Schnack C, Festa A, Schwarzmaier-D'Assié A, et al. Pulmonary dysfunction in type 1 diabetes in relation to metabolic long-term control and to incipient diabetic nephropathy. Nephron. 1996;74:395-400.
17. Davis TM, Knuiman M, Kendall P, et al. Reduced pulmonary function and its associations in type 2 diabetes: the Fremantle Diabetes study. Diabetes Res Clin Pract. 2000;50:153-159.
18. Strojek K, Ziora D, Sroczynski JW, Oklek K. Pulmonary complications of type 1 (insulin-dependent) diabetic patients. Diabetologia. 1992;35:1173-1176.
19. Fuso L, Cotroneo P, Basso S, et al. Postural variations of pulmonary diffusing capacity in insulin-dependent diabetes mellitus. Chest. 1996;110:1009-1013.
20. Benbassat CA, Stern E, Kramer M, et al. Pulmonary function in patients with diabetes mellitus. Am J Med Sci. 2001;322:127-132.
21. Sandler M, Bunn AE, Stewart RI. Cross-section study of pulmonary function in patients with insulin-dependent diabetes mellitus. Am Rev Respir Dis. 1987;135:223-229.
22. Vracko R, Thorning D, Huang TW. Basal lamina of alveolar epithelium and capillaries: quantitive changes with aging and diabetes mellitus. Am Rev Respir Dis. 1979;120:973-983.
23. Kodolova IM, Lysenko LV, Saltykov BB. Changes in the lungs in diabetes mellitus [in Russian]. Arkh Patol. 1982;44:35-40.
24. Mowat A, Baum J. Chemotaxis of polymorphonuclear leukocytes from patients with diabetes mellitus. N Engl J Med. 1971;284:621-627.
25. Ramirez LC, Dal Nogare A, Hsia C, et al. Relationship between diabetes control and pulmonary infection in insulin-dependent diabetes mellitus. Am J Med. 1991;91:371-376.
26. Niranjan V, McBrayer DG, Ramirez LC, et al. Glycemic control and cardiopulmonary function in patients with insulin-dependent diabetes mellitus. Am J Med. 1997;103:504-513.
27. Hsia CC, Raskin P. The diabetic lung: relevance of alveolar microangiopathy for the use of inhaled insulin. Am J Med. 2005;118:205-211.
28. Antonelli Incalzi R, Fuso L, Giordano A, et al. Neuroadrenergic denervation of the lung in type 1 diabetes mellitus complicated by autonomic neuropathy. Chest. 2002;121:443-451.
29. Donowitz GR, Mandell GL. Acute pneumonia. In: Mandell GL, Bennett JE, Dolin R, eds. Principles and Practice of Infectious Diseases. 6th ed. Philadelphia: Churchill and Livingstone; 2005.
30. Lipsky BA, Boyko EJ, Inui TS, Koepsell TD. Risk factors for acquiring pneumococcal infections. Arch Intern Med. 1986;146:2179-2185.
31. Zanobetti A, Schwartz J. Are diabetics more susceptible to the health effects of airborne particles. Am J Respir Crit Care Med. 2001;164:831-833.
32. Sarnak MJ, Jaber BL. Pulmonary infectious mortality among patients with end-stage renal disease. Chest. 2001;120:1883-1887.
33. Kornum JB, Thomsen RW, Riis A, et al. Type 2 diabetes and pneumonia outcomes: a population-based cohort study. Diabetes Care. 2007;30:2251-2257.
34. Thomsen RW, Hundborg HH, Lervang HH, et al. Risk of community-acquired pneumococcal bacteremia in patients with diabetes: a population-based case-control study. Diabetes Care. 2004;27:1143-1147.
35. Almirall J, Bolibar I, Balanzó X, González CA. Risk factors for community-acquired pneumonia in adults: a population-based case-control study. Eur Respir J. 1999;13:349-355.
36. Nuorti JB, Butler JC, Farley MM, et al. Cigarette smoking and invasive pneumococcal disease. Active Bacterial Core Surveillance Team. N Engl J Med. 2000;342:681-689.
37. Akbar DH. Bacterial pneumonia: comparison between diabetics and non-diabetics. Acta Diabetol. 2001;38:77-82.
38. Joshi N, Caputo GM, Wietekamp MR, Karchmer AW. Infections in patients with diabetes mellitus. N Engl J Med. 1999;341:1906-1912.
39. Philips BJ, Redman J, Brennan A, et al. Glucose in bronchial aspirates increases the risk of respiratory MRSA in intubated patients. Thorax. 2005;60:761-764.
40. Graham PL III, Lin SX, Larson EL. A U.S. population-based survey of Staphylococcus aureus colonization. Ann Intern Med. 2006;144:318-325.
41. Tamer A, Karabay O, Ekerbicer H. Staphylococcus aureus nasal carriage and associated factors in type 2 diabetic patients. Jpn J Infect Dis. 2006;59:10-14.
42. Falguera M, Pifarre R, Martin A, et al. Etiology and outcome of community-acquired pneumonia in patients with diabetes mellitus. Chest. 2005;128:3233-3239.
43. Marrie TJ. Bacteraemic pneumococcal pneumonia: a continuously evolving disease. J Infect. 1992;24:247-255.
44. Bouter KP, Diepersloot RJ, van Romunde LK, et al. Effect of epidemic influenza on ketoacidosis, pneumonia and death in diabetes mellitus: a hospital register survey of 1976-1979 in The Netherlands. Diabetes Res Clin Pract. 1991;12:61-68.
45. Houston MS, Silverstein MD, Suman VJ. Risk factors for 30-day mortality in elderly patients with lower respiratory tract infection. Community-based study. Arch Intern Med. 1997;157:2190-2195.
46. Thomsen RW, Hundborg HH, Lervang HH, et al. Diabetes and outcomes of community-acquired pneumococcal bacteremia: a 10-year population-based cohort study. Diabetes Care. 2004;27:70-76.
47. Fine MJ, Smith MA, Carson CA, et al. Prognosis and outcomes of patients with community-acquired pneumonia. A meta-analysis. JAMA. 1996;275:134-141.
48. Gupta S, Koirala J, Khardori R, Khardori N. Infections in diabetes mellitus and hyperglycemia. Infect Dis Clin North Am. 2007;21:617-638.
49. Mackowiak PA, Martin RM, Jones SR, Smith JW. Pharyngeal colonization by gram-negative bacilli in aspiration-prone persons. Arch Intern Med. 1978;138:1224-1227.
50. Aswapokee N, Pruksachatvuthi S, Rungpitarungsi V, Vichayanrat A. Pharyngeal colonization by gram-negative bacilli in ambulatory diabetics. J Med Assoc Thai. 1985;68:243-247.
51. Vardakas KZ, Siempos II, Falagas ME. Diabetes mellitus as a risk factor for nosocomial pneumonia and associated mortality. Diabet Med. 2007;24:1168-1171.
52. Den Boer JW, Nijhof J, Friesema I. Risk factors for sporadic community-acquired Legionnaires' disease. A 3-year national case-control study. Public Health. 2006;120:566-571.
53. Mandell LA, Wunderink RG, Anzueto A, et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis. 2007;44(suppl 2):S27-S72.
54. McAlister FA, Majumdar SR, Blitz S, et al. The relationship between hyperglycemia and outcomes in 2,471 patients admitted to the hospital with community-acquired pneumonia. Diabetes Care. 2005;28:810-815.
55. Krinsley JS. Effect of intensive glucose management protocol on the mortality of critically ill adult patients [published correction appears in Mayo Clin Proc. 2004;80:1101]. Mayo Clin Proc. 2004;79:992-1000.
56. van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in critically ill patients. N Engl J Med. 2001;345:1359-1367.
57. Fine MJ, Auble TE, Yealy DM, et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med. 1997;336:243-250.
58. van de Garde EM, Hak E, Souverein PC, et al. Statin treatment and reduced risk of pneumonia in patients with diabetes. Thorax. 2006;61:957-961.
59. Fitzgerald D, Haas DW. Mycobacterium tuberculosis. In: Mandell GL, Bennett JE, Dolin R, eds. Principles and Practice of Infectious Diseases. 6th ed. Philadelphia: Churchill Livingstone; 2005.
60. Dixon B. Diabetes and tuberculosis: an unhealthy partnership. Lancet Infect Dis. 2007;7:444.
61. Broxmeyer L. Diabetes mellitus, tuberculosis and the mycobacteria: two millenia of enigma. Med Hypotheses. 2005;65:433-439.
62. Restrepo BI. Convergence of the tuberculosis and diabetes epidemics: renewal of old acquaintances. Clin Infect Dis. 2007;45:436-438.
63. Jabbar A, Hussain SF, Khan AA. Clinical characteristics of pulmonary tuberculosis in adult Pakistani patients with co-existing diabetes mellitus. East Mediterr Health J. 2006;12:522-527.
64. Ponce-De-Leon A, Garcia-Garcia Md Mde L, Garcia-Sancho MC, et al. Tuberculosis and diabetes in southern Mexico. Diabetes Care. 2004;27:1584-1590.
65. Stevenson CR, Forouhi NG, Roglic G, et al. Diabetes and tuberculosis: the impact of the diabetes epidemic on tuberculosis incidence. BMC Public Health. 2007;7:234.
66. Pablos-Méndez A, Blustein J, Knirsch CA. The role of diabetes mellitus in the higher prevalence of tuberculosis among Hispanics. Am J Public Health. 1997;87:574-579.
67. Feleke Y, Abdulkadir J, Aderaye G. Prevalence and clinical features of tuberculosis in Ethiopian diabetic patients. East Afr Med J. 1999;76:361-364.
68. Pérez-Guzman C, Torres-Cruz A, Villarreal-Velarde H, et al. Progressive age-related changes in pulmonary tuberculosis images and the effect of diabetes. Am J Respir Crit Care Med. 2000;162:1738-1740.
69. Pérez-Guzman C, Torres-Cruz A, Villareal-Velarde H, et al. Atypical radiological images of pulmonary tuberculosis in 192 diabetic patients: a comparative study. Int J Tuberc Lung Dis. 2001;5:455-461.
70. Alisjahbana B, Sahiratmadja E, Nelwan EJ, et al. The effect of type 2 diabetes mellitus on the presentation and treatment response of pulmonary tuberculosis. Clin Infect Dis. 2007;45:428-435.
71. Singla R, Khan N. Does diabetes predispose to the development of multidrug-resistant tuberculosis? Chest. 2003;123:308-309.
72. Bashar M, Aloabes P, Rom WN, Condos R. Increased incidence of multidrug-resistant tuberculosis in diabetic patients on the Bellevue Chest Service, 1987 to 1997. Chest. 2001;120:1514-1519.
73. Barker WH, Mullooly JP. Pneumonia and influenza deaths during epidemics: implications for prevention. Arch Intern Med. 1982;142:85-89.
74. Rubin SA, Chaljub G, Winer-Muram HT, Flicker S. Pulmonary zygomycosis: a radiographic and clinical spectrum. J Thorac Imaging. 1992;7:85-90.
75. Walsh TJ, Anaissie EJ, Denning DW, et al. Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis. 2008;46:327-360.
76. Rosenstein NE, Emery KW, Werner SB, et al. Risk factors for severe pulmonary and disseminated coccidioidomycosis: Kern County, California, 1995-1996. Clin Infect Dis. 2001;32:708-715.
77. Santelli AC, Blair JE, Roust LR. Coccidioidomycosis in patients with diabetes mellitus. Am J Med. 2006;119:964-969.
78. Pappas PG, Rex JH, Sobel JD, et al. Guidelines for treatment of candidiasis. Clin Infect Dis. 2004;38:161-189.